Skip to main content

EMD

Emyria (ASX: EMD) has performed well since I last looked at them. They were at 2.9 cents in the middle of July, and now they're at 5.9 cents. Not bad for 6 months.

I like where these guys are going... they are growing well and, it looks like they are tracking ahead of their plans. All is looking very good. A stellar year ahead is the prediction for EMD. As as they continue to open more clinics they are just going to look better and better. 

Here's the thing... I know that the hospital at Albury (NSW) is sooking about needing a new hospital and desperately hitting the Vic government up for funding, which ain't coming.

Imagine if they took a different approach. Imagine if they actually rang Emyria and had a chat along these lines: How can we work together to achieve your goals and ours? Imagine that.

And then if Albury hospital repeated that model with other biotechs? Everyone wins.

Comments

Popular posts from this blog

BOT

 As far as quarterly announcements go, the one out today from BOT is one of the nest I have ever seen. And it only get beaten by the next quarterly. The only way this stock is going is up - with the potential of a takeover offer (nothing is certain).

It's 31 Jan

 And that means we will hear about the AAR T/O offer of MXR today or tomorrow. Considering that MXR have not been sitting idle while AAR have been going through the data, I would like to think that the offer will be increased. Already the offer is at 7 cents (AAR scrip equivalent) in a share swap - no you don't get the cash, you get the shares in AAR. As I wrwite this, MXR is still at 6.3 cents, so there could be a quick profit to be made for those who can jump fast.

A Couple of Updates

 Well, it's Monday morning and the week has started with a bang. First, PFE announced that there was an unexpected problem with their test drill and they have had to abandon that and go to a new test drill site. A delay, but no real issue apart from that. And the market hated that. Good news for those wanting to buy, not so good for existing holders. IMC released their AGM presentation which indicates that there will be some news in December and then a very busy (and hopefully productive) 2025. Sales are good and continuing to get better and better.